Search Results

It took data, yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility

Terry Kenakin's educational initiative this fall!

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry Kenakin. Kenakin, access to a dedicated group, course materials, recordings, and a completion certificate endorsed Kenakin and Dr. GPCR.

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Only ten spots remain. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin.

Terry Kenakin will lead two brand-new, back-to-back courses tailored for the Dr.

Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings once the course is completed Kenakin and Dr. GPCR Access to Dr.

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin, starts February 8th, 2024. Due to popular demand, we have opened additional spots. Kenakin in a small group setting, hurry and register today. Only three spots remain. Kenakin Access to the cohort’s Dr. Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings once the course is completed Kenakin and Dr. GPCR Access to Dr.

Terry Kenakin, Dr. Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr.

Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry Kenakin, was a resounding success; we have a waitlist for those eager to attend this course, which

Terry Kenakin.

Terry Kenakin.

Terry Kenakin. We would like to extend our heartfelt thanks to Dr. Kenakin for his invaluable contributions and to all the participants for their active involvement and Chain Reaction Orphan GPR52 as an emerging neurotherapeutic target Sustained antidepressant effects of ketamine

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin, have been amazing.

Terry Kenakin. Mark your calendars because registration opens on July 18, 2024!

Terry Kenakin will conduct two back-to-back courses this fall.

Terry Kenakin will return with two back-to-back classes.

Terry Kenakin.

Terry Kenakin’s Applying Pharmacology to Drug Discovery course.

Ho, ho, ho, GPCR elves! As the year wraps up, we're thrilled to present the final edition of the GPCR Weekly Newsletter for 2024! As researchers, we all understand the importance of data in driving meaningful discoveries  and advancing our experiments.   At Dr. GPCR, we believe the same principle applies to building a better experience  for our online community.   We’d love to hear your thoughts on our website and its features  so that we can continue to support your work and foster collaborations in the GPCR field.   Your feedback  will guide us in tailoring resources , tools , and content to meet your needs better and help fuel your research. Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! Best, Yamina & the Dr. GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with prestigious events, including receiving the British Pharmacological Society Vane Medal and switching on the Christmas lights at the University of Glasgow Advanced Research Centre! Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Luke A Pattison , Rebecca H Rickman , Graham Ladds , Ewan St John Smith , et al. Attention, everyone! This is your last chance before the curtain closes: Classified GPCR News will be accessible only to VIP members next year! Indeed, all the details below will be limited to Premium Members . Don't miss out—upgrade now to keep up with your GPCR updates! Classified GPCR News  Let’s dive into the   Classified GPCR News from December 9th to 15th, 2024 Industry News When science meets serendipity: How accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's GPCR and TPD Structural Biology Platforms GPCR Events, Meetings, and Webinars December 10 - 12, 2024 | Pharmacology 2024 January 13 - 16, 2025 | PepTalk 2025 January 25 - 29, 2025 | SLAS 2025 February 15 - 16, 2025 | Structural and Functional Approaches in GPCR Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox Summit April 1 - 5, 2025 | XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural Biologist GPCR Activation and Signaling Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Regulation of the chemokine receptors CXCR4 and ACKR3 by receptor activity-modifying proteins Single-cell transcriptomics of vomeronasal neuroepithelium reveals a differential endoplasmic reticulum environment amongst neuronal subtypes Methods & Updates in GPCR Research High-throughput optimisation of protein secretion in yeast via an engineered biosensor Optimized vector for functional expression of the human bitter taste receptor TAS2R14 in HEK293 cells Reviews, GPCRs, and more The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy Become a Premium Member! Get your 5-day free trial TODAY!

Kenakin walks through this as a living system , showing how GPCRs exist in multiple conformations and Allosteric Interactions Only in Terry’s Corner 🎬 Plus New: Lesson Trailers   Curious about Terry’s Corner Kenakin     💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr. That’s where Terry’s Corner changes the game. Subscribe to The Kenakin Brief  today ➤

Kenakin reveals how decision-making on early safety hinges on the ability to pinpoint liabilities—such Kenakin highlights the definitive role of patch clamp assays and how high-throughput adaptations have Kenakin clarifies that both direct hepatotoxic effects and conditional toxicities, such as those driven Kenakin demonstrates how mechanistic assays allow for early warning, ensuring that compounds prone to ’s Corner Terry’s Pharmacology Corner delivers weekly in-depth lectures by Dr.

. 👉 Unlock Irreversible Drugs —  Only in Terry’s Corner! Kenakin  will get released next month, featuring real questions from discovery scientists tackling enzyme Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief  today ➤